224 related articles for article (PubMed ID: 32317666)
1. MG132 exerts anti-viral activity against HSV-1 by overcoming virus-mediated suppression of the ERK signaling pathway.
Ishimaru H; Hosokawa K; Sugimoto A; Tanaka R; Watanabe T; Fujimuro M
Sci Rep; 2020 Apr; 10(1):6671. PubMed ID: 32317666
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of proteasome inhibitors in herpes simplex virus-1 infection: role of nuclear factor-kappaB.
La Frazia S; Amici C; Santoro MG
Antivir Ther; 2006; 11(8):995-1004. PubMed ID: 17302369
[TBL] [Abstract][Full Text] [Related]
3. Early Steps in Herpes Simplex Virus Infection Blocked by a Proteasome Inhibitor.
Schneider SM; Pritchard SM; Wudiri GA; Trammell CE; Nicola AV
mBio; 2019 May; 10(3):. PubMed ID: 31088925
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells.
Faith SA; Sweet TJ; Bailey E; Booth T; Docherty JJ
Antiviral Res; 2006 Dec; 72(3):242-51. PubMed ID: 16876885
[TBL] [Abstract][Full Text] [Related]
5. Antiviral mechanism of carvacrol on HSV-2 infectivity through inhibition of RIP3-mediated programmed cell necrosis pathway and ubiquitin-proteasome system in BSC-1 cells.
Wang L; Wang D; Wu X; Xu R; Li Y
BMC Infect Dis; 2020 Nov; 20(1):832. PubMed ID: 33176697
[TBL] [Abstract][Full Text] [Related]
6. BX-795 inhibits HSV-1 and HSV-2 replication by blocking the JNK/p38 pathways without interfering with PDK1 activity in host cells.
Su AR; Qiu M; Li YL; Xu WT; Song SW; Wang XH; Song HY; Zheng N; Wu ZW
Acta Pharmacol Sin; 2017 Mar; 38(3):402-414. PubMed ID: 28112176
[TBL] [Abstract][Full Text] [Related]
7. UBE1a Suppresses Herpes Simplex Virus-1 Replication.
Ikeda M; Ito A; Sekine Y; Fujimuro M
Viruses; 2020 Dec; 12(12):. PubMed ID: 33291814
[TBL] [Abstract][Full Text] [Related]
8. Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication.
Luganini A; Sibille G; Mognetti B; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Gribaudo G
Antiviral Res; 2021 May; 189():105057. PubMed ID: 33716051
[TBL] [Abstract][Full Text] [Related]
9. Samarangenin B from Limonium sinense suppresses herpes simplex virus type 1 replication in Vero cells by regulation of viral macromolecular synthesis.
Kuo YC; Lin LC; Tsai WJ; Chou CJ; Kung SH; Ho YH
Antimicrob Agents Chemother; 2002 Sep; 46(9):2854-64. PubMed ID: 12183238
[TBL] [Abstract][Full Text] [Related]
10. Boswellia serrata oleo-gum-resin and β-boswellic acid inhibits HSV-1 infection in vitro through modulation of NF-кB and p38 MAP kinase signaling.
Goswami D; Mahapatra AD; Banerjee S; Kar A; Ojha D; Mukherjee PK; Chattopadhyay D
Phytomedicine; 2018 Dec; 51():94-103. PubMed ID: 30466633
[TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibitors: a novel tool to suppress human cytomegalovirus replication and virus-induced immune modulation.
Prösch S; Priemer C; Höflich C; Liebenthaf C; Babel N; Krüger DH; Volk HD
Antivir Ther; 2003 Dec; 8(6):555-67. PubMed ID: 14760889
[TBL] [Abstract][Full Text] [Related]
12. Antiviral Properties of the LSD1 Inhibitor SP-2509.
Harancher MR; Packard JE; Cowan SP; DeLuca NA; Dembowski JA
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699090
[TBL] [Abstract][Full Text] [Related]
13. Opposite Roles of RNase and Kinase Activities of Inositol-Requiring Enzyme 1 (IRE1) on HSV-1 Replication.
Su A; Wang H; Li Y; Wang X; Chen D; Wu Z
Viruses; 2017 Aug; 9(9):. PubMed ID: 28832521
[TBL] [Abstract][Full Text] [Related]
14. Zinc ionophores pyrithione inhibits herpes simplex virus replication through interfering with proteasome function and NF-κB activation.
Qiu M; Chen Y; Chu Y; Song S; Yang N; Gao J; Wu Z
Antiviral Res; 2013 Oct; 100(1):44-53. PubMed ID: 23867132
[TBL] [Abstract][Full Text] [Related]
15. Activation of I kappa b kinase by herpes simplex virus type 1. A novel target for anti-herpetic therapy.
Amici C; Belardo G; Rossi A; Santoro MG
J Biol Chem; 2001 Aug; 276(31):28759-66. PubMed ID: 11387335
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of PHA767491 against human herpes simplex virus in vitro and in vivo.
Hou J; Zhang Z; Huang Q; Yan J; Zhang X; Yu X; Tan G; Zheng C; Xu F; He S
BMC Infect Dis; 2017 Mar; 17(1):217. PubMed ID: 28320320
[TBL] [Abstract][Full Text] [Related]
17. Wogonin inhibits in vitro herpes simplex virus type 1 and 2 infection by modulating cellular NF-κB and MAPK pathways.
Chu Y; Lv X; Zhang L; Fu X; Song S; Su A; Chen D; Xu L; Wang Y; Wu Z; Yun Z
BMC Microbiol; 2020 Jul; 20(1):227. PubMed ID: 32723300
[TBL] [Abstract][Full Text] [Related]
18. In vitro antiviral activity of dehydroepiandrosterone, 17 synthetic analogs and ERK modulators against herpes simplex virus type 1.
Torres NI; Castilla V; Bruttomesso AC; Eiras J; Galagovsky LR; Wachsman MB
Antiviral Res; 2012 Jul; 95(1):37-48. PubMed ID: 22584352
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of cellular c-Jun N-terminal protein kinase and NF-κB activation by berberine may result in inhibition of herpes simplex virus replication.
Song S; Qiu M; Chu Y; Chen D; Wang X; Su A; Wu Z
Antimicrob Agents Chemother; 2014 Sep; 58(9):5068-78. PubMed ID: 24913175
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus 1 infection induces ubiquitination of UBE1a.
Ikeda M; Watanabe T; Ito A; Fujimuro M
Biochem J; 2021 Jan; 478(1):261-279. PubMed ID: 33355669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
